Literature DB >> 34617306

Tau-Atrophy Variability Reveals Phenotypic Heterogeneity in Alzheimer's Disease.

Sandhitsu R Das1, Xueying Lyu2, Michael Tran Duong2, Long Xie3, Lauren McCollum4, Robin de Flores5, Michael DiCalogero1, David J Irwin1, Bradford C Dickerson6, Ilya M Nasrallah3, Paul A Yushkevich3, David A Wolk1.   

Abstract

OBJECTIVE: Tau neurofibrillary tangles (T) are the primary driver of downstream neurodegeneration (N) and subsequent cognitive impairment in Alzheimer's disease (AD). However, there is substantial variability in the T-N relationship - manifested in higher or lower atrophy than expected for level of tau in a given brain region. The goal of this study was to determine if region-based quantitation of this variability allows for identification of underlying modulatory factors, including polypathology.
METHODS: Cortical thickness (N) and 18 F-Flortaucipir SUVR (T) were computed in 104 gray matter regions from a cohort of cognitively-impaired, amyloid-positive (A+) individuals. Region-specific residuals from a robust linear fit between SUVR and cortical thickness were computed as a surrogate for T-N mismatch. A summary T-N mismatch metric defined using residuals were correlated with demographic and imaging-based modulatory factors, and to partition the cohort into data-driven subgroups.
RESULTS: The summary T-N mismatch metric correlated with underlying factors such as age and burden of white matter hyperintensity lesions. Data-driven subgroups based on clustering of residuals appear to represent different biologically relevant phenotypes, with groups showing distinct spatial patterns of higher or lower atrophy than expected.
INTERPRETATION: These data support the notion that a measure of deviation from a normative relationship between tau burden and neurodegeneration across brain regions in individuals on the AD continuum captures variability due to multiple underlying factors, and can reveal phenotypes, which if validated, may help identify possible contributors to neurodegeneration in addition to tau, which may ultimately be useful for cohort selection in clinical trials. ANN NEUROL 2021;90:751-762.
© 2021 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34617306      PMCID: PMC8841129          DOI: 10.1002/ana.26233

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  38 in total

1.  Longitudinal and cross-sectional structural magnetic resonance imaging correlates of AV-1451 uptake.

Authors:  Sandhitsu R Das; Long Xie; Laura E M Wisse; Ranjit Ittyerah; Nicholas J Tustison; Bradford C Dickerson; Paul A Yushkevich; David A Wolk
Journal:  Neurobiol Aging       Date:  2018-02-09       Impact factor: 4.673

2.  Hippocampal pathology reflects memory deficit and brain imaging measurements in Alzheimer's disease: clinicopathologic correlations using three sets of pathologic diagnostic criteria.

Authors:  Z Nagy; K A Jobst; M M Esiri; J H Morris; E M King; B MacDonald; S Litchfield; L Barnetson; A D Smith
Journal:  Dementia       Date:  1996 Mar-Apr

3.  Limbic-predominant age-related TDP-43 encephalopathy (LATE).

Authors:  Andrew J Larner; Timothy D Griffiths
Journal:  Brain       Date:  2019-08-01       Impact factor: 13.501

Review 4.  Primary progressive aphasia: clinicopathological correlations.

Authors:  Murray Grossman
Journal:  Nat Rev Neurol       Date:  2010-02       Impact factor: 42.937

Review 5.  Early-onset Alzheimer Disease and Its Variants.

Authors:  Mario F Mendez
Journal:  Continuum (Minneap Minn)       Date:  2019-02

6.  PET Imaging of Tau Deposition in the Aging Human Brain.

Authors:  Michael Schöll; Samuel N Lockhart; Daniel R Schonhaut; James P O'Neil; Mustafa Janabi; Rik Ossenkoppele; Suzanne L Baker; Jacob W Vogel; Jamie Faria; Henry D Schwimmer; Gil D Rabinovici; William J Jagust
Journal:  Neuron       Date:  2016-03-02       Impact factor: 17.173

7.  The contribution of small vessel disease to subtypes of Alzheimer's disease: a study on cerebrospinal fluid and imaging biomarkers.

Authors:  Daniel Ferreira; Sara Shams; Lena Cavallin; Matti Viitanen; Juha Martola; Tobias Granberg; Mana Shams; Peter Aspelin; Maria Kristoffersen-Wiberg; Agneta Nordberg; Lars-Olof Wahlund; Eric Westman
Journal:  Neurobiol Aging       Date:  2018-05-30       Impact factor: 4.673

Review 8.  Diagnosis of neurodegenerative dementia: where do we stand, now?

Authors:  Giulia M Sancesario; Sergio Bernardini
Journal:  Ann Transl Med       Date:  2018-09

Review 9.  NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

Authors:  Clifford R Jack; David A Bennett; Kaj Blennow; Maria C Carrillo; Billy Dunn; Samantha Budd Haeberlein; David M Holtzman; William Jagust; Frank Jessen; Jason Karlawish; Enchi Liu; Jose Luis Molinuevo; Thomas Montine; Creighton Phelps; Katherine P Rankin; Christopher C Rowe; Philip Scheltens; Eric Siemers; Heather M Snyder; Reisa Sperling
Journal:  Alzheimers Dement       Date:  2018-04       Impact factor: 21.566

10.  Heterogeneity in Suspected Non-Alzheimer Disease Pathophysiology Among Clinically Normal Older Individuals.

Authors:  Elizabeth C Mormino; Kathryn V Papp; Dorene M Rentz; Aaron P Schultz; Molly LaPoint; Rebecca Amariglio; Bernard Hanseeuw; Gad A Marshall; Trey Hedden; Keith A Johnson; Reisa A Sperling
Journal:  JAMA Neurol       Date:  2016-10-01       Impact factor: 18.302

View more
  4 in total

Review 1.  Recent update on the heterogeneity of the Alzheimer's disease spectrum.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2021-12-17       Impact factor: 3.575

Review 2.  Limbic-Predominant Age-Related TDP-43 Encephalopathy: LATE-Breaking Updates in Clinicopathologic Features and Biomarkers.

Authors:  Michael Tran Duong; David A Wolk
Journal:  Curr Neurol Neurosci Rep       Date:  2022-10-03       Impact factor: 6.030

3.  Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer's disease.

Authors:  Michael Tran Duong; Sandhitsu R Das; Xueying Lyu; Long Xie; Hayley Richardson; Sharon X Xie; Paul A Yushkevich; David A Wolk; Ilya M Nasrallah
Journal:  Nat Commun       Date:  2022-03-21       Impact factor: 17.694

Review 4.  Imaging Clinical Subtypes and Associated Brain Networks in Alzheimer's Disease.

Authors:  Karl Herholz
Journal:  Brain Sci       Date:  2022-01-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.